| Synonyms | Trileptal; 10-OH Carbamazepine (MHD) |
| SPECIMEN REQUIREMENTS | |
| Container Type | Red top tube (plain) |
| Supply Item Number | 1372 |
| Specimen Type | Serum |
| Preferred Volume | 1 mL |
| Emergency Minimum Volume | 0.5 mL |
| Patient Prep | Pre-dose (trough) levels should be drawn |
| Specimen Processing | Separate serum or plasma from cells within 2 hours of collection. |
| Store and Transport | Refrigerated |
| Stability | Room Temp 2 weeks Refrigerated 2 weeks Frozen (-20 °C) 1 month |
| Limitations | Hyponatremia can develop during oxcarbazepine therapy. |
| Reference Laboratory | PAML |
| Reference Lab Test Code | LCA code 911184 |
| CPT Codes | 80183 |
| Interface Order Code | 80299.Z55 |
| Billing Code | OXCAR |
| Test Schedule | Mon-Fri |
| Turnaround Time | 1-3 days |
| Method | Tandem Mass Spectrometry |
| Reference Ranges | | Title | Descriptor | Ranges | Units | | Oxcarbazepine Metabolite | | 10-35 | ug/mL |
|
| Compliance Remarks | This test was developed and its performance characteristics determined by PAML. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test. However, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. PAML is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing. |
| Notes | This test measures monohydroxyoxcarbazepine (MHD). |
